Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Merck & Co Inc (NYSE:MRK) announced the presentation of results from two Phase 3 trials of doravirine/islatravir (DOR/ISL) in ...

Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically ...

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.

American Society of Regional Anesthesia and Pain Medicine guidelines highlight SSI prevention in regional anesthesia and ...

A newer class of diabetes drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors has been linked to a rare but ...

Post-acute neuropsychiatric symptoms triggered by COVID-19 could raise the long-term use of multiple psychoactive drugs in LTC residents.

The child was rushed out of the Women In Need (WIN) shelter on Glenwood Road near Schenectady Ave. in East Flatbush about 8 a.m. Tuesday.

Discover how new global guidelines aim to combat the rising threat of Candida infections with updated treatments and ...

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

Stat: Gilead Data Suggests Yearly Shot Of PrEP Drug Blocks HIV Infection Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection ...